How many individuals will need to be screened to increase colorectal cancer screening prevalence to 80% by 2018?

Cancer

Volumn 121, Issue 23, 2015, Pages 4258-4265

  Fedewa, Stacey A ^a,b   Ma, Jiemin ^a   Sauer, Ann Goding ^a   Siegel, Rebecca L ^a   Smith, Robert A ^a   Wender, Richard C ^a   Doroshenk, Mary K ^a   Brawley, Otis W ^a   Ward, Elizabeth M ^a   Jemal, Ahmedin ^a  

^a AMERICAN CANCER SOCIETY   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

cancer screening; colorectal neoplasms; National Colorectal Cancer Roundtable; public health; socioeconomic status

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; CANCER SCREENING; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SEX; UNITED STATES; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; MASS SCREENING; MIDDLE AGED; MORTALITY; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TRENDS;

AGED; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MODELS, STATISTICAL; PREVALENCE; UNITED STATES;

EID: 84948570019     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29659     Document Type: Article

References (48)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5-29.
2. Yang DX, Gross CP, Soulos PR, Yu JB. Estimating the magnitude of colorectal cancers prevented during the era of screening: 1976 to 2009. Cancer. 2014;120:2893-2901.
3. Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116:544-573.
4. Fedewa SA, Sauer AG, Siegel RL, Jemal A. Prevalence of major risk factors and use of screening tests for cancer in the United States. Cancer Epidemiol Biomarkers Prev. 2015;24:637-652.
5. Smith RA, Manassaram-Baptiste D, Brooks D, et al. Cancer screening in the United States, 2015: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2015;65:30-54.
6. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149:627-637.
7. National Colorectal Cancer Roundtable. About the Roundtable. Available at: http://nccrt.org/about/. Accessed May 1, 2015.
8. Meester RG, Doubeni CA, Zauber AG, et al. Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018 [published online ahead of print March 12, 2015]. Cancer. doi: 10.1002/cncr.29336.
9. Centers for Disease Control and Prevention. National Health Interview Survey, 2013. Public-use data file and documentation. Available at: http://www.cdc.gov/nchs/nhis/quest-data-related-1997-forward. htm. Accessed July 16, 2014.
10. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System 2012 Summary Data Quality Report. Atlanta, GA: Centers for Disease Control and Prevention; 2012.
11. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System Survey Data and Documentation. Available at: http://www.cdc.gov/brfss/data-documentation/index.htm. Accessed April 20, 2015.
12. United States Census Bureau. Population projections. Available at: http://www.census.gov/population/projections/. Accessed March 2, 2015.
13. Fahimi M, Link M, Mokdad A, Schwartz DA, Levy P. Tracking chronic disease and risk behavior prevalence as survey participation declines: statistics from the Behavioral Risk Factor Surveillance System and other national surveys. Prev Chronic Dis. 2008;5:A80.
14. Rauscher GH, Johnson TP, Cho YI, Walk JA. Accuracy of selfreported cancer-screening histories: a meta-Analysis. Cancer Epidemiol Biomarkers Prev. 2008;17:748-757.
15. Ma J, Ward EM, Smith R, Jemal A. Annual number of lung cancer deaths potentially avertable by screening in the United States. Cancer. 2013;119:1381-1385.
16. Oehlert G. A note on the Delta Method. Am Stat. 1992;46:27-29.
17. Guessous I, Dash C, Lapin P, et al. Colorectal cancer screening barriers and facilitators in older persons. Prev Med. 2010;50:3-10.
18. Shapiro JA, Klabunde CN, Thompson TD, Nadel MR, Seeff LC, White A. Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev. 2012;21:895-904.
19. Steinwachs D, Allen JD, Barlow WE, et al. National Institutes of Health state-of-Dhe-science conference statement: enhancing use and quality of colorectal cancer screening. Ann Intern Med. 2010;152: 663-667.
20. Laiyemo AO, Adebogun AO, Doubeni CA, et al. Influence of provider discussion and specific recommendation on colorectal cancer screening uptake among U.S. adults. Prev Med. 2014;67:1-5.
21. Inadomi JM, Vijan S, Janz NK, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012;172:575-582.
22. Yabroff KR, Klabunde CN, Yuan G, et al. Are physicians recommendations for colorectal cancer screening guideline-consistent? J Gen Intern Med. 2011;26:177-184.
23. Guerra CE, Schwartz JS, Armstrong K, Brown JS, Halbert CH, Shea JA. Barriers of and facilitators to physician recommendation of colorectal cancer screening. J Gen Intern Med. 2007;22:1681-1688.
24. Lee JK, Levin TR, Corley DA. The road ahead: what if gastroenterologists were accountable for preventing colorectal cancer? Clin Gastroenterol Hepatol. 2013;11:204-207.
25. American Cancer Society. Cancer Prevention and Early Detection Facts & Figures 2015-2016. Atlanta, GA: American Cancer Society; 2015.
26. Jemal A, Siegel RL, Ma J, et al. Inequalities in premature death from colorectal cancer by state. J Clin Oncol. 2015;33:829-835.
27. Kaiser Family Foundation. Massachusetts health care reform: six years later. Available at: https://kaiserfamilyfoundation.files.wordpress. com/2013/01/8311.pdf. Accessed May 3, 2015.
28. Martinez ME, Cohen RA. Health insurance coverage: early release of estimates from the National Health Interview Survey, January-September 2014. Available at: http://www.cdc.gov/nchs/data/nhis/earlyrelease/insur201503.pdf. Accessed March 25, 2015.
29. Jones RM, Woolf SH, Cunningham TD, et al. The relative importance of patient-reported barriers to colorectal cancer screening. Am J Prev Med. 2010;38:499-507.
30. Denberg TD, Melhado TV, Coombes JM, et al. Predictors of nonadherence to screening colonoscopy. J Gen Intern Med. 2005;20: 989-995.
31. Cram P, Fendrick AM, Inadomi J, Cowen ME, Carpenter D, Vijan S. The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect. Arch Intern Med. 2003;163:1601-1605.
32. Holden DJ, Jonas DE, Porterfield DS, Reuland D, Harris R. Systematic review: enhancing the use and quality of colorectal cancer screening. Ann Intern Med. 2010;152:668-676.
33. Percac-Lima S, Lopez L, Ashburner JM, Green AR, Atlas SJ. The longitudinal impact of patient navigation on equity in colorectal cancer screening in a large primary care network. Cancer. 2014;120: 2025-2031.
34. Lasser KE, Murillo J, Lisboa S, et al. Colorectal cancer screening among ethnically diverse, low-income patients: a randomized controlled trial. Arch Intern Med. 2011;171:906-912.
35. Jones RM, Devers KJ, Kuzel AJ, Woolf SH. Patient-reported barriers to colorectal cancer screening: a mixed-methods analysis. Am J Prev Med. 2010;38:508-516.
36. Doubeni CA, Laiyemo AO, Young AC, et al. Primary care, economic barriers to health care, and use of colorectal cancer screening tests among Medicare enrollees over time. Ann Fam Med. 2010;8: 299-307.
37. OMalley AS, Forrest CB, Feng S, Mandelblatt J. Disparities despite coverage: gaps in colorectal cancer screening among Medicare beneficiaries. Arch Intern Med. 2005;165:2129-2135.
38. Koh HK, Sebelius KG. Promoting prevention through the Affordable Care Act. N Engl J Med. 2010;363:1296-1299.
39. Department of Health and Human Services. The Affordable Care Act and Medicare. Washington DC: Department of Health and Human Services; 2014.
40. Vijan S, Inadomi J, Hayward RA, Hofer TP, Fendrick AM. Projections of demand and capacity for colonoscopy related to increasing rates of colorectal cancer screening in the United States. Aliment Pharmacol Ther. 2004;20:507-515.
41. Ladabaum U, Song K. Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand. Gastroenterology. 2005;129:1151-1162.
42. Seeff LC, Manninen DL, Dong FB, et al. Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States? Gastroenterology. 2004;127:1661-1669.
43. Aboagye JK, Kaiser HE, Hayanga AJ. Rural-urban differences in access to specialist providers of colorectal cancer care in the United States: a physician workforce issue [published online ahead of print April 16, 2014]. JAMA Surg. doi: 10.1001/jamasurg.2013.5062.
44. Haas JS, Brawarsky P, Iyer A, et al. Association of local capacity for endoscopy with individual use of colorectal cancer screening and stage at diagnosis. Cancer. 2010;116:2922-2931.
45. Soneji S, Armstrong K, Asch DA. Socioeconomic and physician supply determinants of racial disparities in colorectal cancer screening. J Oncol Pract. 2012;8:e125-e134.
46. White A, Vernon SW, Eberth JM, et al. Correlates of self-reported colorectal cancer screening accuracy in a multi-specialty medical group practice. Open J Epidemiol. 2013;3:20-24.
47. Fenton JJ, Elmore JG, Buist DS, Reid RJ, Tancredi DJ, Baldwin LM. Longitudinal adherence with fecal occult blood test screening in community practice. Ann Fam Med. 2010;8:397-401.
48. Centers for Disease Control and Prevention. National Health Interview Survey: questionnaires, datasets, and related documentation 1997 to the present. Available at: http://www.cdc.gov/nchs/nhis/quest-data-related-1997-forward.htm. Accessed March 10, 2015.